Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 28

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 28
---
 as consumers may have reduced purchasing power, prompting them to opt for lower-cost alternatives. Should global economic conditions worsen, or in the event of default or failure of major players including wholesalers or public sector buyers financed by insolvent states, Sanofi's financial situation, profitability, operational results, and distribution channels of products could be adversely affected. See also “— We are subject to the risk of non-payment by our customers” above. A failure in our crisis and business continuity management processes in case of unpredictable events could have negative consequences for our business, operations, and reputation We have increased crisis preparedness and response in recent years due in particular to crises such as the COVID-19 pandemic and ongoing war in Ukraine and conflicts in the Middle East. Nevertheless, unpredictable and extraordinary internal or external events, or a combination of escalating events that may occur as a result of a large scale cyber-attack (see also “— Breaches of data security, disruptions of information technology systems and cyber threats could result in financial, legal, competitive, operational, business or reputational harm” above), a pandemic or natural disasters, could result in the failure of critical processes within Sanofi or a third party on whom we rely. Moreover, lack of resources and/or low maturity level in crisis management of our service providers faced with an increasing number of major international crises may hamper our ability to implement our business continuity plans. Such failure or limited implementation of our business continuity plans may adversely impact our business, operations, and reputation. The occurrence of these unforeseen events may also heighten other risks such as a disruption or temporary suspension in production of active pharmaceutical ingredients, raw materials and some of other products and/or lead to manufacturing delays or disruptions and supply chain interruptions (including to the extent those measures apply to our third-party suppliers) and may have an adverse effect on our business (see “— The manufacture of our products is technically complex, and supply interruptions, product recalls or inventory losses caused by unforeseen events may reduce sales, adversely affect our operating results and financial condition, delay the launch of new products and negatively impact our image” above). Also, a sudden increase in demand for selected medicinal products in the event of a crisis can result in short-term unavailability or shortages of raw materials.

| SANOFIFORM 20-F2024 | 11 |

| PART I                  |
| ITEM 3. Key Information |

Climate change or legal, regulatory or market measures to address climate change may negatively affect our business and results of operations Climate change resulting from increased concentrations of carbon dioxide and